vs
Side-by-side financial comparison of ACACIA RESEARCH CORP (ACTG) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
ACACIA RESEARCH CORP is the larger business by last-quarter revenue ($50.1M vs $39.6M, roughly 1.3× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 6.8%, a 29.1% gap on every dollar of revenue. On growth, ACACIA RESEARCH CORP posted the faster year-over-year revenue change (2.6% vs -10.9%). Over the past eight quarters, ACACIA RESEARCH CORP's revenue compounded faster (43.6% CAGR vs -15.0%).
Acacia Research Corporation is a publicly traded American company based in New York City. It acquires and operates businesses in industries including the technology, energy, and industrial/manufacturing sectors. Acacia has a strategic relationship with Starboard Value, LP, the company's controlling shareholder. The company has been characterized as a patent troll.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
ACTG vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $50.1M | $39.6M |
| Net Profit | $3.4M | $14.2M |
| Gross Margin | 12.8% | 73.1% |
| Operating Margin | -26.1% | 32.5% |
| Net Margin | 6.8% | 35.9% |
| Revenue YoY | 2.6% | -10.9% |
| Net Profit YoY | 125.5% | 117.2% |
| EPS (diluted) | $0.03 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $50.1M | $39.6M | ||
| Q3 25 | $59.4M | $43.4M | ||
| Q2 25 | $51.2M | $43.4M | ||
| Q1 25 | $124.4M | $47.3M | ||
| Q4 24 | $48.8M | $44.4M | ||
| Q3 24 | $23.3M | $53.1M | ||
| Q2 24 | $25.8M | $53.1M | ||
| Q1 24 | $24.3M | $54.8M |
| Q4 25 | $3.4M | $14.2M | ||
| Q3 25 | $-2.7M | $12.8M | ||
| Q2 25 | $-3.3M | $2.5M | ||
| Q1 25 | $24.3M | $21.5M | ||
| Q4 24 | $-13.4M | $6.5M | ||
| Q3 24 | $-14.0M | $2.8M | ||
| Q2 24 | $-8.4M | $18.5M | ||
| Q1 24 | $-186.0K | $18.8M |
| Q4 25 | 12.8% | 73.1% | ||
| Q3 25 | 21.2% | 70.6% | ||
| Q2 25 | 12.8% | 69.2% | ||
| Q1 25 | 47.4% | 79.7% | ||
| Q4 24 | 17.6% | 76.3% | ||
| Q3 24 | 10.1% | 81.5% | ||
| Q2 24 | 26.2% | 74.2% | ||
| Q1 24 | 49.2% | 72.1% |
| Q4 25 | -26.1% | 32.5% | ||
| Q3 25 | -10.8% | 36.6% | ||
| Q2 25 | -24.2% | 33.6% | ||
| Q1 25 | 30.8% | 51.1% | ||
| Q4 24 | -32.4% | 10.6% | ||
| Q3 24 | -44.1% | 26.1% | ||
| Q2 24 | -18.4% | 51.4% | ||
| Q1 24 | -8.6% | 44.6% |
| Q4 25 | 6.8% | 35.9% | ||
| Q3 25 | -4.6% | 29.6% | ||
| Q2 25 | -6.4% | 5.7% | ||
| Q1 25 | 19.5% | 45.4% | ||
| Q4 24 | -27.5% | 14.7% | ||
| Q3 24 | -60.0% | 5.3% | ||
| Q2 24 | -32.7% | 34.8% | ||
| Q1 24 | -0.8% | 34.2% |
| Q4 25 | $0.03 | $0.15 | ||
| Q3 25 | $-0.03 | $0.12 | ||
| Q2 25 | $-0.03 | $0.02 | ||
| Q1 25 | $0.25 | $0.21 | ||
| Q4 24 | $-0.14 | $0.05 | ||
| Q3 24 | $-0.14 | $0.03 | ||
| Q2 24 | $-0.08 | $0.20 | ||
| Q1 24 | $0.00 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $306.7M | $164.1M |
| Total DebtLower is stronger | $91.9M | $42.8M |
| Stockholders' EquityBook value | $543.5M | $248.3M |
| Total Assets | $771.0M | $380.4M |
| Debt / EquityLower = less leverage | 0.17× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $306.7M | $164.1M | ||
| Q3 25 | $301.8M | $127.4M | ||
| Q2 25 | $316.7M | $152.7M | ||
| Q1 25 | $272.0M | $132.1M | ||
| Q4 24 | $273.9M | $125.0M | ||
| Q3 24 | $410.9M | $137.4M | ||
| Q2 24 | $441.9M | — | ||
| Q1 24 | $498.4M | — |
| Q4 25 | $91.9M | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $543.5M | $248.3M | ||
| Q3 25 | $537.6M | $248.0M | ||
| Q2 25 | $538.6M | $244.6M | ||
| Q1 25 | $540.2M | $226.4M | ||
| Q4 24 | $514.8M | $195.1M | ||
| Q3 24 | $540.2M | $205.0M | ||
| Q2 24 | $560.7M | $8.8M | ||
| Q1 24 | $568.3M | $9.0M |
| Q4 25 | $771.0M | $380.4M | ||
| Q3 25 | $768.9M | $321.4M | ||
| Q2 25 | $775.5M | $315.3M | ||
| Q1 25 | $801.6M | $284.6M | ||
| Q4 24 | $756.4M | $266.1M | ||
| Q3 24 | $707.6M | $296.5M | ||
| Q2 24 | $753.6M | $19.5M | ||
| Q1 24 | $631.7M | $19.8M |
| Q4 25 | 0.17× | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $75.2M | $52.0M |
| Free Cash FlowOCF − Capex | — | $51.2M |
| FCF MarginFCF / Revenue | — | 129.3% |
| Capex IntensityCapex / Revenue | — | 2.0% |
| Cash ConversionOCF / Net Profit | 22.01× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | — | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $75.2M | $52.0M | ||
| Q3 25 | $9.5M | $-20.9M | ||
| Q2 25 | $50.1M | $-8.3M | ||
| Q1 25 | $2.4M | $1.9M | ||
| Q4 24 | $50.1M | $-7.3M | ||
| Q3 24 | $-593.0K | $5.0M | ||
| Q2 24 | $16.1M | $19.2M | ||
| Q1 24 | $54.8M | $3.7M |
| Q4 25 | — | $51.2M | ||
| Q3 25 | — | $-20.9M | ||
| Q2 25 | — | $-8.6M | ||
| Q1 25 | $335.0K | $1.7M | ||
| Q4 24 | $-98.5M | $-7.9M | ||
| Q3 24 | $-2.8M | $4.6M | ||
| Q2 24 | $-126.7M | $18.3M | ||
| Q1 24 | $54.6M | $3.0M |
| Q4 25 | — | 129.3% | ||
| Q3 25 | — | -48.3% | ||
| Q2 25 | — | -19.9% | ||
| Q1 25 | 0.3% | 3.5% | ||
| Q4 24 | -201.8% | -17.8% | ||
| Q3 24 | -12.1% | 8.7% | ||
| Q2 24 | -490.5% | 34.5% | ||
| Q1 24 | 224.4% | 5.4% |
| Q4 25 | — | 2.0% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | 1.7% | 0.5% | ||
| Q4 24 | 304.4% | 1.3% | ||
| Q3 24 | 9.6% | 0.8% | ||
| Q2 24 | 553.0% | 1.6% | ||
| Q1 24 | 1.1% | 1.3% |
| Q4 25 | 22.01× | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | 0.10× | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACTG
| Energy Operations | $16.0M | 32% |
| Transportation Safety | $10.4M | 21% |
| Office Storage And Display Solutions | $8.4M | 17% |
| Printers Consumables And Parts | $6.5M | 13% |
| Natural Gas Reserves | $5.1M | 10% |
| Natural Gas Liquids Reserves | $3.3M | 7% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
